Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | CES1 | P23141 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | JAK2 | O60674 | 1/20 | 0.51 |
| ▸ | JAK1 | P23458 | 1/20 | 0.51 |
| ▸ | TYK2 | P29597 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.49 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.49 |
| ▸ | ITGAL | P20701 | 1/20 | 0.49 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | PPIA | P62937 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29570977 | 1.00 | GAA (0.56) | GAACES2CES1ALDH1A1JAK2 | |
| Hydrochloric Acid SCHEMBL11347862 | 0.98 | GAA (0.54) | GAACES2CES1ALDH1A1JAK2 | |
| SCHEMBL28687902 | 0.98 | GAA (0.54) | GAACES2CES1ALDH1A1JAK2 | |
| Methyl Alcohol SCHEMBL28365833 | 0.96 | GAA (0.53) | GAACES2CES1ALDH1A1JAK2 | |
| Toluene SCHEMBL28365312 | 0.89 | GAA (0.54) | GAACES2CES1JAK2JAK1 | |
| Ether SCHEMBL27813454 | 0.86 | GAA (0.45) | GAACES2CES1ALDH1A1JAK2 | |
| SCHEMBL2876974 | 0.84 | GAA (0.58) | GAACES2CES1ALDH1A1JAK2 | |
| SCHEMBL260553 | 0.84 | CES2 (0.67) | CES2CES1JAK2JAK1TYK2 | |
| SCHEMBL80183 | 0.84 | ALDH1A1 (0.64) | CES2CES1ALDH1A1KMT2AMEN1 | |
| SCHEMBL10460251 | 0.83 | GAA (0.46) | GAAJAK2JAK1TYK2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 701 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-119285656-A | Rare earth complex fluorescent material, ultrasonic synthesis method and application thereof | 河北师范大学 | 2025-01-10 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-116396159-A | Synthesis method of 2,2' -biphenyl dicarboxylic acid compound | 湖南大学 | 2023-07-07 | — | — | CN | claimed |
| CN-113861007-B | Method for disposing 2-chloro-6 fluorobenzaldehyde distillation residues | 浙江大洋生物科技集团股份有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-110724050-B | Refining method of 2-chloro-6-fluorobenzoic acid | 浙江大洋生物科技集团股份有限公司 | 2022-04-22 | — | — | CN | claimed |
| CN-114181076-A | Preparation method of 2, 6-dihalogenated methyl benzoate | 维思普新材料（苏州）有限公司 | 2022-03-15 | — | — | CN | claimed |
| CN-113861007-A | Method for treating distillation residue of 2-chloro-6-fluorobenzaldehyde | 浙江大洋生物科技集团股份有限公司 | 2021-12-31 | — | — | CN | claimed |
| EP-3551633-B1 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | LEO PHARMA AS (DK) | 2021-03-31 | — | — | EP | claimed |
| CN-110818556-A | Method for producing high-purity 2-chloro-6-fluorobenzoyl chloride by using waste residues | 浙江大洋生物科技集团股份有限公司 | 2020-02-21 | — | — | CN | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| WO-2005075471-A2 | THIAZOL-COMPOUNDS AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS | BIOVITRUM AB (SE) | 2005-08-18 | — | — | WO | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-5354495-A | Homo- or copolymerizable through ethylenic unsaturation | NIPPON PAINT CO., LTD. (JP) | 1994-10-11 | — | — | US | claimed |
| EP-0177122-B1 | ACRYLAMIDE DERIVATIVES | Nippon Paint Co., Ltd. (JP) | 1992-04-01 | — | — | EP | claimed |
| US-4411974-A | FOR NEGATIVE TONERS | XEROX CORPORATION (US) | 1983-10-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | GAA 1358/4885CES2 1598/4885CES1 3489/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | GAA 958/4885CES2 2351/4885CES1 3786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.